Photocure ASA (0IMT.L)
NOK 60.8
(7.99%)
NOK 60.8
(7.99%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 63.75 Million NOK | 855.58% |
| 2022 | -20.75 Million NOK | -160.25% |
| 2021 | 16.82 Million NOK | 463.5% |
| 2020 | -15.76 Million NOK | -89.91% |
| 2019 | 44.3 Million NOK | 1490.23% |
| 2018 | -10.49 Million NOK | 111.2% |
| 2017 | -33.09 Million NOK | 6.21% |
| 2016 | -8 Million NOK | -301.32% |
| 2015 | -18.08 Million NOK | -393.1% |
| 2014 | -4.16 Million NOK | 104.86% |
| 2013 | -66.98 Million NOK | -109.84% |
| 2012 | -31.66 Million NOK | 33.13% |
| 2011 | -43.96 Million NOK | -283.29% |
| 2010 | 23.98 Million NOK | 139.0% |
| 2009 | -75.04 Million NOK | -31.62% |
| 2008 | -67.12 Million NOK | 45.71% |
| 2007 | -73.56 Million NOK | -207.03% |
| 2006 | 79.67 Million NOK | 253.11% |
| 2005 | -37.28 Million NOK | -8.76% |
| 2004 | -43.68 Million NOK | 7.1% |
| 2003 | -51.97 Million NOK | 51.99% |
| 2002 | -108.25 Million NOK | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 49.71 Million NOK | 93.57% |
| 2024 Q1 | 30.4 Million NOK | -62.11% |
| 2023 Q3 | 9.94 Million NOK | -63.79% |
| 2023 Q4 | 51.02 Million NOK | 412.88% |
| 2023 Q2 | 27.47 Million NOK | 490.18% |
| 2023 Q1 | 4.65 Million NOK | 124.79% |
| 2023 FY | - NOK | 855.58% |
| 2022 Q4 | -18.77 Million NOK | -342.02% |
| 2022 Q3 | 7.75 Million NOK | 114.34% |
| 2022 Q2 | 3.62 Million NOK | 126.71% |
| 2022 Q1 | -13.55 Million NOK | -28.95% |
| 2022 FY | - NOK | -160.25% |
| 2021 Q3 | 2.88 Million NOK | -50.37% |
| 2021 FY | - NOK | 463.5% |
| 2021 Q2 | 5.82 Million NOK | -83.72% |
| 2021 Q1 | 35.74 Million NOK | 1127.58% |
| 2021 Q4 | -10.51 Million NOK | -463.79% |
| 2020 Q3 | 4.99 Million NOK | 216.31% |
| 2020 Q2 | -4.29 Million NOK | -283.58% |
| 2020 Q1 | 2.33 Million NOK | -95.44% |
| 2020 FY | - NOK | -89.91% |
| 2020 Q4 | 2.91 Million NOK | -41.67% |
| 2019 Q2 | -2.41 Million NOK | -2771.43% |
| 2019 Q4 | 51.27 Million NOK | 404.18% |
| 2019 Q1 | -84 Thousand NOK | -101.04% |
| 2019 FY | - NOK | 1490.23% |
| 2019 Q3 | 10.17 Million NOK | 521.64% |
| 2018 Q2 | 1.35 Million NOK | 140.08% |
| 2018 Q4 | 8.06 Million NOK | 446.56% |
| 2018 FY | - NOK | 111.2% |
| 2018 Q1 | -3.38 Million NOK | 77.93% |
| 2018 Q3 | -2.32 Million NOK | -271.53% |
| 2017 Q1 | -6.6 Million NOK | 79.42% |
| 2017 FY | - NOK | 6.21% |
| 2017 Q4 | -15.33 Million NOK | -83.15% |
| 2017 Q3 | -8.37 Million NOK | -200.22% |
| 2017 Q2 | -2.78 Million NOK | 57.8% |
| 2016 Q1 | -2.43 Million NOK | 61.11% |
| 2016 FY | - NOK | -301.32% |
| 2016 Q4 | -32.11 Million NOK | -8354.76% |
| 2016 Q3 | 389 Thousand NOK | 134.52% |
| 2016 Q2 | -1.12 Million NOK | 53.75% |
| 2015 Q4 | -6.26 Million NOK | -287.51% |
| 2015 Q3 | -1.61 Million NOK | -333.33% |
| 2015 Q2 | 693 Thousand NOK | 116.96% |
| 2015 Q1 | -4.08 Million NOK | 42.4% |
| 2015 FY | - NOK | -393.1% |
| 2014 Q2 | -3.62 Million NOK | 69.73% |
| 2014 Q3 | 25.7 Million NOK | 808.68% |
| 2014 Q4 | -7.09 Million NOK | -127.6% |
| 2014 FY | - NOK | 104.86% |
| 2014 Q1 | -11.98 Million NOK | 33.48% |
| 2013 Q3 | -12.23 Million NOK | -28.45% |
| 2013 Q4 | -18.01 Million NOK | -47.28% |
| 2013 Q2 | -9.52 Million NOK | 54.08% |
| 2013 Q1 | -20.73 Million NOK | -226.79% |
| 2013 FY | - NOK | -109.84% |
| 2012 Q1 | -9.93 Million NOK | -94.31% |
| 2012 FY | - NOK | 33.13% |
| 2012 Q3 | -23.55 Million NOK | -538.47% |
| 2012 Q2 | -3.68 Million NOK | 62.87% |
| 2012 Q4 | 16.35 Million NOK | 169.44% |
| 2011 Q3 | -5.33 Million NOK | 68.31% |
| 2011 Q1 | -17.2 Million NOK | -26.17% |
| 2011 Q2 | -16.83 Million NOK | 2.15% |
| 2011 Q4 | -5.11 Million NOK | 4.13% |
| 2011 FY | - NOK | -283.29% |
| 2010 Q4 | -13.63 Million NOK | -23.03% |
| 2010 Q2 | 59.03 Million NOK | 564.97% |
| 2010 Q3 | -11.08 Million NOK | -118.77% |
| 2010 FY | - NOK | 139.0% |
| 2010 Q1 | -12.69 Million NOK | 45.72% |
| 2009 Q2 | -22.9 Million NOK | -151.8% |
| 2009 Q4 | -23.39 Million NOK | -154.32% |
| 2009 FY | - NOK | -31.62% |
| 2009 Q1 | -9.09 Million NOK | 0.0% |
| 2009 Q3 | -9.19 Million NOK | 59.85% |
| 2008 FY | - NOK | 45.71% |
| 2007 FY | - NOK | -207.03% |
| 2006 FY | - NOK | 253.11% |
| 2005 FY | - NOK | -8.76% |
| 2004 FY | - NOK | 7.1% |
| 2003 FY | - NOK | 51.99% |
| 2002 FY | - NOK | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| BerGenBio ASA | -191.8 Million NOK | 133.24% |